Physician profile
Karen Camera
NPI 1346252707
$809.55
in general payments reported to CMS, 2019-2025
11 companies · $123 in 2025
The $123 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.00 · 2022: $64.60 · 2023: $552 · 2024: $51.15 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699 · Debt Forgiveness: $27.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.03 |
| Debt Forgiveness | $27.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $175.71 | 2022-2025 | Bexsero, Penmenvy |
| Supernus Pharmaceuticals, INC. | $124.91 | 2023 | Qelbree |
| Astrazeneca Pharmaceuticals LP | $109.09 | 2023 | Tezspire |
| Amgen INC. | $109.09 | 2023 | Tezspire |
| Sanofi Pasteur INC. | $69.68 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $53.79 | 2024-2025 | Gardasil 9, M-M-R II, Vaxelis |
| Kaleo, INC. | $51.93 | 2022-2023 | Auvi-Q |
| Corium, LLC | $51.11 | 2023-2025 | Azstarys |
| Baxter Healthcare | $27.92 | 2024 | |
| Alk-Abello, INC | $22.85 | 2025 | Neffy |
| Kowa Pharmaceuticals America, INC. | $13.47 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Camera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.